Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension
- 1 January 2018
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 82 (1), 275-282
- https://doi.org/10.1253/circj.cj-17-0139
Abstract
Background:The trend of the initial treatment strategy for pulmonary arterial hypertension (PAH) has changed from monotherapies to upfront combination therapies. This study analyzed treatments and outcomes in Japanese patients with PAH, using data from the Japan PH Registry (JAPHR), which is the first organized multicenter registry for PAH in Japan. Methods and Results:We studied 189 consecutive patients (108 treatment-naïve and 81 background therapy patients) with PAH in 8 pulmonary hypertension (PH) centers enrolled from April 2008 to March 2013. We performed retrospective survival analyses and analyzed the association between upfront combination and hemodynamic improvement, adjusting for baseline NYHA classification status. Among the 189 patients, 1-, 2-, and 3-year survival rates were 97.0% (95% CI: 92.1–98.4), 92.6% (95% CI: 87.0–95.9), and 88.2% (95% CI: 81.3–92.7), respectively. In the treatment-naïve cohort, 33% of the patients received upfront combination therapy. In this cohort, 1-, 2-, and 3-year survival rates were 97.6% (95% CI: 90.6–99.4), 97.6% (95% CI: 90.6–99.4), and 95.7% (95% CI: 86.9–98.6), respectively. Patients on upfront combination therapy were 5.27-fold more likely to show hemodynamic improvement at the first follow-up compared with monotherapy (95% CI: 2.68–10.36). Conclusions:According to JAPHR data, initial upfront combination therapy is associated with improvement in hemodynamic status.Keywords
This publication has 17 references indexed in Scilit:
- IgG4-related disease in pulmonary arterial hypertension on long-term epoprostenol treatmentEuropean Respiratory Journal, 2014
- An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL RegistrySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Pulmonary hypertension: the science behind the disease spectrumEuropean Respiratory Review, 2012
- Japanese universal health coverage: evolution, achievements, and challengesThe Lancet, 2011
- Integration of Clinical and Hemodynamic Parameters in the Prediction of Long-term Survival in Patients With Pulmonary Arterial HypertensionSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2011
- Compelling Evidence of Long-Term Outcomes in Pulmonary Arterial Hypertension?: A Clinical PerspectiveJournal of the American College of Cardiology, 2011
- The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United StatesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2011
- Predicting Survival in Pulmonary Arterial HypertensionCirculation, 2010
- An epidemiological study of pulmonary arterial hypertensionEuropean Respiratory Journal, 2007
- Pulmonary Arterial Hypertension in FranceAmerican Journal of Respiratory and Critical Care Medicine, 2006